Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Wellcome Trust
Wellcome Trust
X
LinkedIn
Trending Articles
ICROM has acquired HOLODIAG
ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of...
Blood plasma processing: when every drop counts
Plasma derivatives obtained from human blood support the treatment of various diseases — from haemophilia and antigen defects to COVID-19. The products are in high demand and...
Rentschler Biopharma boosts UK end-to-end lentiviral vector manufacturing capabilities
The company can now develop and produce LVVs for the biopharmaceutical market, which have a high potential in treating a range of diseases
IC Biomedical confirms Biopharma Group as its cryogenic storage vessel service provider
IC Biomedical has designated Biopharma Group as its Premier Service Provider for the full range of cryogenic storage vessels across the UK and Ireland
What’s the difference between a factory acceptance test and site acceptance testing?
When manufacturing complex machinery in industries such as pharmaceuticals or fine chemicals, extensive equipment testing must be carried out before commissioning
Upcoming event
Boston Biotech Week
23-26 September, 2024 | Convention and exhibition | Boston, US
See all
Related Content
Research & Development
Oxford clinical trial for COVID-19 treatments expands internationally
The international trial will initially focus on the treatments aspirin and colchicine, since these are readily available and affordable
Research & Development
Study demonstrates way to target hard-to-treat cancer mutation
The study was funded by Cancer Research UK and Wellcome
Research & Development
Collaborators use CRISPR to catch cancer-causing gene fusions
A team from the Wellcome Sanger Institute and collaborators have identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian
Finance
Karuna completes $42 million financing round
Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed investors
Hi Tech Manufacturing
£10m research competition to tackle antimicrobial resistance
Move aims to encourage the development of innovative scientific approaches to addressing antimicrobial resistance
Regulatory
Karuna receives $8m Wellcome Trust award
The funding will be used to advance the company's lead product candidate, KarXT, through a Phase II study in people with schizophrenia
Research & Development
Polyphor and Wellcome Trust to develop novel antibiotics against multi-drug resistant Gram-negative pathogens
Final milestone reached ahead of schedule triggering payment of a CHF 0.97 million convertible loan amount
Subscribe now